Intel Capital leads $15m series B funding for Prism Skylabs, a technology startup which aims to boost brick-and-mortar businesses by attaching web-style analytics to their in-store video cameras.

Biotechnology company Biodesy raises $15m series A funding led by 5AM Ventures and including Pfizer Venture Investments and Roche Venture Fund, to develop and commercialize its technology for real-time measurement of changes in protein structure.

Enterproid changes name into Divide, after its secure mobile platform for BYOD-based enterprises, and raises $12m series B funding led by Google Ventures and including Comcast Ventures and Qualcomm Ventures.

Basis Science, maker of the Basis wristband for collecting personal health data, extends series B financing by $11.75m to $23m, with investments from Intel Capital, Stanford University and others.

Celgene Corporation commits $35m to biopharmaceutical company PharmAkea in strategic alliance to develop therapeutics for cancer and fibrosis.

IDG Capital Partners, the corporate venturing unit of the IDG research group, has invested close to $10m in Wacai, a Chinese personal finance app developer. The series A round follows on from a June 2011 angel investment of close to 10 million yuan ($1.6m), bringing its funding to date at about $11.6m.